Fieldfisher has advised biotechnology company, Link Biologics, on their co-equity fundraising for their innovative dry eye disease (DED) program in partnership with Théa Open Innovation, assisted...
Link Biologics’ Fundraising With Théa Open Innovation For Dry Eye Disease Program
Complement Therapeutics’ €5 Million seed Financing Round
Fieldfisher advised Complement Therapeutics on the deal. Complement Therapeutics Ltd (CTx), a preclinical stage University of Manchester spinout, raised €5 million through a seed financing round from...